Neurovascular Devices Market By Type (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Neurothrombectomy Devices, Support Devices), By Indication (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The neurovascular devices market is expected to exhibit lucrative growth during the forecast period.

The global neurovascular devices market is expanding rapidly, with a value of US$ 1,863.0 million in 2017 and a projected value of US$ 3,257.1 million by 2026. Increasing demand for minimally invasive procedures, the growing commonness of neurovascular disorders and stroke, and rapid new product development and commercialization drive the overall neurovascular devices market’s growth. The overall market would be driven by technological advancements in stenting technique, coiling procedure technique, cerebral angiography technique, and flow disruption technique.

Market Synopsis

The cerebral balloon angioplasty and stenting technology segment are expected to register higher growth by the end of 2026.

The global market for neurovascular devices is expanding rapidly, primarily in the Asia Pacific, the Middle East, and Europe. The availability of a wide range of neurovascular devices, mainly in the aneurysm coiling and embolization devices segment, enables professionals to meet the active demand.

Other major factors driving the growth include product expansion for carotid stents and balloon catheters among neurologists; increasing admissions of patients suffering from atherosclerosis or ischemic strokes; developments in the nature and number of multispecialty hospitals and neurosurgical centers, and enhanced reimbursement structures across developing nations.

A stroke in the indication segment generated the highest revenue share in 2018.

According to the statistics presented by the Centers for Disease Control and Prevention (CDC), more than 795,000 individuals in the United States experience a stroke every year. Thus, the high prevalence of movement disabilities due to stroke and its treatment with the help of embolization coils and stents in rehabilitation centers and hospitals will drive the market.

A cerebral aneurysm is expected to be the fastest-growing indication globally during the forecast period. Around 2% to 4% of the worldwide population suffers from cerebral aneurysms, which are mostly treated with stents and embolization coils.

During the forecast period, market growth will be driven by an aging population in developed countries.

The increasing elderly population and the corresponding prevalence of cerebrovascular disorders will drive the overall growth in the end-user segment. As per the Internet Stroke Center statistics, around 75% of strokes take place in the age group of 60–65.

The ever-changing dynamics in critical care and the demand for advanced treatment techniques, along with the increasing number of neurovascular cases among the elderly population, are generating a significant revenue share.

For example, with the introduction of the new flow diversion stent technique, the need to treat complex aneurysms with bypasses has fallen. However, a lack of skilled neurologists in hospitals is limiting the growth of the neurovascular devices market.

Increasing demand for advanced products and the presence of established players hold North America in a dominant position.

The U.S. generated the largest revenue share in the global neurovascular devices market. Furthermore, rapid commercialization of novel devices and strong pipeline candidates under FDA scrutiny would further drive the U.S. and, therefore, North American markets. However, in developing economic regions such as Latin America and Asia-Pacific, the availability of advanced technology is inadequate.

The high procedural costs, along with the need for skilled professionals, are restraining the overall market’s growth. Huge patient populations in the Asia Pacific, growing demands for minimally invasive surgeries, enhanced reimbursement structures, and partnerships with or acquisitions of medical device manufacturers internationally will drive market growth significantly.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the neurovascular devices market are Penumbra, Inc., Phenox GmbH, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Merit Medical Systems, Inc., W. L. Gore & Associates, Inc., Johnson & Johnson, MicroPort Scientific Corporation, Delaware Corporation, Rapid Medical, Medtronic plc, and others. Companies are executing growth strategies through technological advancement, new product launches, and expansion into hospitals and rehabilitation centers.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities, which provide a more comprehensive understanding of the overall neurovascular devices market. Additionally, the report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

• What are the current market trends and dynamics in the neurovascular devices market, and what are the valuable opportunities for emerging players?
• Which segment accounts for the fastest CAGR during the forecast period?
• What is the impact of the high cost of neurovascular devices on the global market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global ND Market Portraiture
2.2. Global ND Market, by Type, 2017 (US$ Mn)
2.3. Global ND Market, by Indication, 2017 (US$ Mn)
2.4. Global ND Market, by End User, 2017 (US$ Mn)
2.5. Global ND Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Neurovascular Devices (ND) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Neurovascular Device Technologies: Market Trends
3.3. Current Scenario: Mergers & New Product Launches
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2017
3.8. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Neurovascular Devices (ND) Market, by Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Aneurysm Coiling & Embolization Devices (Embolic Coils, Flow Diversion Devices)
4.3. Cerebral Balloon Angioplasty & Stenting Systems (Stents, Protecting Systems)
4.4. Neurothrombectomy Devices (Aspiration Devices, Snares, Clot Retrievers)
4.5. Support Devices (Catheters, Guidewires)

Chapter 5. Global Neurovascular Devices (ND) Market, by Indication, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Stroke
5.3. Cerebral Artery Stenosis
5.4. Cerebral Aneurysm
5.5. Others (Atherosclerosis, Arteriovenous Malformation (AVM))

Chapter 6. Global Neurovascular Devices (ND) Market, by End User, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Hospitals
6.3. Clinics
6.4. Ambulatory Surgical Centers

Chapter 7. Global Neurovascular Devices (ND) Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America ND Market Analysis, 2016 – 2026
7.2.1. North America ND Market, by Type, 2016 – 2026 (US$ Mn)
7.2.2. North America ND Market, by Indication, 2016 – 2026 (US$ Mn)
7.2.3. North America ND Market, by End User, 2016 – 2026 (US$ Mn)
7.2.4. North America ND Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe ND Market Analysis, 2016 – 2026
7.3.1. Europe ND Market, by Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe ND Market, by Indication, 2016 – 2026 (US$ Mn)
7.3.3. Europe ND Market, by End User, 2016 – 2026 (US$ Mn)
7.3.4. Europe ND Market, by Country, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific ND Market Analysis, 2016 – 2026
7.4.1. Asia Pacific ND Market, by Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific ND Market, by Indication, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific ND Market, by End User, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific ND Market, by Country, 2016 – 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America ND Market Analysis, 2016 – 2026
7.5.1. Latin America ND Market, by Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America ND Market, by Indication, 2016 – 2026 (US$ Mn)
7.5.3. Latin America ND Market, by End User, 2016 – 2026 (US$ Mn)
7.5.4. Latin America ND Market, by Country, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) ND Market Analysis, 2016 – 2026
7.6.1. MEA ND Market, by Type, 2016 – 2026 (US$ Mn)
7.6.2. MEA ND Market, by Indication, 2016 – 2026 (US$ Mn)
7.6.3. MEA ND Market, by End User, 2016 – 2026 (US$ Mn)
7.6.4. MEA ND Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Stryker Corporation
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Penumbra, Inc.
8.3. Phenox GmbH
8.4. Terumo Corporation
8.5. Abbott Laboratories
8.6. Merit Medical Systems, Inc.
8.7. W. L. Gore & Associates, Inc.
8.8. MicroPort Scientific Corporation
8.9. Johnson & Johnson
8.10. Medtronic plc
8.11. Delaware Corporation
8.12. Rapid Medical

List of Figures

FIG. 1 : Global Neurovascular Devices (ND) Market: Research Methodology
FIG. 2 : Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 : Global ND Market Segmentation
FIG. 4 : Global ND Market, by Type, 2017 (US$ Mn)
FIG. 5 : Global ND Market, by Indication, 2017 (US$ Mn)
FIG. 6 : Global ND Market, by End User, 2017 (US$ Mn)
FIG. 7 : Global ND Market, by Geography, 2017 (US$ Mn)
FIG. 8 : Attractive Investment Proposition, by Geography, 2017
FIG. 9 : Global Market Positioning of Key ND Manufacturers, 2017
FIG. 10 : Global Aneurysm Coiling & Embolization Devices Market, 2016–2026 (US$ Mn)
FIG. 11 : Global Cerebral Balloon Angioplasty & Stenting Systems Market, 2016–2026 (US$ Mn)
FIG. 12 : Global Neurothrombectomy Devices Market, 2016–2026 (US$ Mn)
FIG. 13 : Global Support Devices Market, 2016–2026 (US$ Mn)
FIG. 14 : Global ND for Stroke Market, 2016–2026 (US$ Mn)
FIG. 15 : Global ND for Cerebral Artery Stenosis Market, 2016–2026 (US$ Mn)
FIG. 16 : Global ND for Cerebral Aneurysm Market, 2016–2026 (US$ Mn)
FIG. 17 : Global ND for Other Indications Market, 2016–2026 (US$ Mn)
FIG. 18 : Global ND Market in Hospitals, 2016–2026 (US$ Mn)
FIG. 19 : Global ND in Clinics, 2016–2026 (US$ Mn)
FIG. 20 : Global ND in Ambulatory Surgical Centers, 2016–2026 (US$ Mn)
FIG. 21 : U.S. ND Market, 2016–2026 (US$ Mn)
FIG. 22 : Canada ND Market, 2016–2026 (US$ Mn)
FIG. 23 : U.K. ND Market, 2016–2026 (US$ Mn)
FIG. 24 : Germany ND Market, 2016–2026 (US$ Mn)
FIG. 25 : Rest of Europe ND Market, 2016–2026 (US$ Mn)
FIG. 26 : Japan ND Market, 2016–2026 (US$ Mn)
FIG. 27 : China ND Market, 2016–2026 (US$ Mn)
FIG. 28 : Rest of Asia Pacific ND Market, 2016–2026 (US$ Mn)
FIG. 29 : Brazil ND Market, 2016–2026 (US$ Mn)
FIG. 30 : Mexico ND Market, 2016–2026 (US$ Mn)
FIG. 31 : Rest of Latin America ND Market, 2016–2026 (US$ Mn)
FIG. 32 : GCC ND Market, 2016–2026 (US$ Mn)
FIG. 33 : Rest of Middle East & Africa ND Market, 2016–2026 (US$ Mn)

List of Tables

TABLE 1 : Market Snapshot: Global Neurovascular Devices (ND) Market
TABLE 2 : Global ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 3 : Global ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 4 : Global ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 5 : Global ND Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 : North America ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 7 : North America ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 8 : North America ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 9 : North America ND Market, by Country, 2016–2026 (US$ Mn)
TABLE 10 : Europe ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 11 : Europe ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 12 : Europe ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 : Europe ND Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 : Asia Pacific ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 15 : Asia Pacific ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 16 : Asia Pacific ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 17 : Asia Pacific ND Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 18 : Latin America ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 19 : Latin America ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 20 : Latin America ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 21 : Latin America ND Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 22 : Middle East & Africa ND Market, by Type, 2016–2026 (US$ Mn)
TABLE 23 : Middle East & Africa ND Market, by Indication, 2016–2026 (US$ Mn)
TABLE 24 : Middle East & Africa ND Market, by End User, 2016–2026 (US$ Mn)
TABLE 25 : Middle East & Africa ND Market, by Region, 2016–2026 (US$ Mn)
TABLE 26 : Stryker Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 : Penumbra, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 : Phenox GmbH: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 : Terumo Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 : Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 : Merit Medical Systems, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 : W. L. Gore & Associates, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 : MicroPort Scientific Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 : Johnson & Johnson: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 : Medtronic plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 : Delaware Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 : Rapid Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)